Real-World Effectiveness of 9-12 Months of Guselkumab Therapy among Patients with Moderate-to-Severe Plaque Psoriasis in the CorEvitas Psoriasis Registry.

Armstrong, April W; Fitzgerald, Timothy; McLean, Robert R; Teeple, Amanda; Uy, Jonathan P; Olurinde, Mobolaji; Rowland, Katelyn; Guo, Lin; Shan, Ying; Callis Duffin, Kristina

Real-World Effectiveness of 9-12 Months of Guselkumab Therapy among Patients with Moderate-to-Severe Plaque Psoriasis in the CorEvitas Psoriasis Registry.

Armstrong, April W; Fitzgerald, Timothy; McLean, Robert R; Teeple, Amanda; Uy, Jonathan P; Olurinde, Mobolaji; Rowland, Katelyn; Guo, Lin; Shan, Ying; Callis Duffin, Kristina.

Afiliação

Armstrong AW; University of Southern California, Los Angeles, CA, USA.
Fitzgerald T; Harvard Medical School, Boston, MA, USA.
McLean RR; Janssen Scientific Affairs LLC, 800 Ridgeview Drive, Horsham, PA, 19044, USA. TFitzg11@its.jnj.com.
Teeple A; CorEvitas, LLC, Waltham, MA, USA.
Uy JP; Janssen Scientific Affairs LLC, 800 Ridgeview Drive, Horsham, PA, 19044, USA.
Olurinde M; Janssen Scientific Affairs LLC, 800 Ridgeview Drive, Horsham, PA, 19044, USA.
Rowland K; Janssen Scientific Affairs LLC, 800 Ridgeview Drive, Horsham, PA, 19044, USA.
Guo L; Janssen Scientific Affairs LLC, 800 Ridgeview Drive, Horsham, PA, 19044, USA.
Shan Y; CorEvitas, LLC, Waltham, MA, USA.
Callis Duffin K; CorEvitas, LLC, Waltham, MA, USA.